05:43 GMT +316 July 2019
Listen Live
    Abdelaziz Bouteflika

    Bouteflika to Leave Country for Medical Treatment After Stepping Down - Reports

    © AP Photo / Kayhan Ozer/Pool
    Africa
    Get short URL
    0 10

    CAIRO (Sputnik) - Ex-Algerian President Abdelaziz Bouteflika will travel to Qatar or Switzerland in April to receive medical treatment, Algerie-Direct reported on Friday, citing sources.

    According to the Algerie-Direct news outlet, the former Algerian president will travel to receive medical treatment in either an American clinic in Doha or a hospital in Geneva.

    The 82-year-old Bouteflika stepped down from his position on Tuesday by handing a resignation letter to the Constitutional Council, following months-long protests in Algeria demanding a change of power. The politician cited Article 102 as a cause for his resignation which states that a leader can step down if they are inhibited from performing their presidential duties due to medical reasons.

    READ MORE: Algerian Constitutional Council Endorses Bouteflika's Resignation — Reports

    Bouteflika served four terms as president since assuming office in 1999. In February this year, the leader announced his intention to seek a new presidential bid. The announcement quickly prompted large waves of anti-government protests, the largest in over a decade. Bouteflika finally surrendered to the demonstrators' demands and said he would not seek a new term.

    The Algerian government must now organise new elections to fill the presidential vacancy, with Abdelkader Bensalah, the head of the country's upper chamber, acting as interim president.

    Related:

    Ex-Algerian President Bouteflika Addresses Nation, Asks for Forgiveness
    Algerian Constitutional Council Endorses Bouteflika's Resignation - Reports
    Algeria's Bouteflika Promises Smooth Transition of Power After Resignation
    Algeria's President Bouteflika Resigns - Reports
    Tags:
    medical treatment, medical aid, Abdelaziz Bouteflika, Algeria
    Community standardsDiscussion
    Comment via FacebookComment via Sputnik